MétaCan
ENFR
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

Export CSVExport JSONAPI query

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
British Journal of Dermatology
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

688 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
688 works in the cohort · of 4,299,418page 1 of 14

Labels cover 4 of 688 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 688 of 688 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

affgemma · no categorygpt · no categorymodels agree
Efficacy and safety of risankizumab vs. secukinumab in patients with moderate‐to‐severe plaque psoriasis (IMMerge): results from a phase III, randomized, open‐label, efficacy–assessor‐blinded clinical trial*
Richard B. Warren, Andrew Blauvelt, Yves Poulin, Stefan Beeck, Matt Kelly, Tianshuang Wu +2 more
2020· article· en· British Journal of Dermatology· Immunology and Microbiology
distilled prediction:candidate · metaepi_narrowconsensus · none
206
citations
affunlabeled
Sunscreen photoprotection and vitamin D status
Thierry Passeron, Roger Bouillon, Valerie Callender, Tânia Ferreira Cestari, Thomas L. Diepgen, Adèle C. Green +9 more
2019· review· en· British Journal of Dermatology· Medicine
distilled prediction:candidate · noneconsensus · none
193
citations
affunlabeled
Efficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: a randomized, double-blind, vehicle-controlled clinical trial
Lyn Guenther, F. Cambazard, P.C.M. van de Kerkhof, Erna Snellman, Knud Kragballe, A.C. Chu +3 more
2002· article· en· British Journal of Dermatology· Immunology and Microbiology
distilled prediction:candidate · noneconsensus · none
174
citations
affunlabeled
Redefining Rowell’s syndrome
Nathalie C. Zeitouni, Deana Funaro, Richard Cloutier, Éric Gagné, Joël Claveau
2000· article· en· British Journal of Dermatology· Medicine
distilled prediction:candidate · insufficient_payloadconsensus · none
171
citations
next →

How this was built: Screen · Findings · About